Clinical trials: Differential Renal Function

Overweight , Obesity

A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants

• Active, not recruiting
• Age: 18 to 75 years
• Phase 1

This study is a single-dose, open-label, parallel design phase I clinical study to evaluate the PK characteristics and safety of single subcutaneous injection of ZT002 Injection in participants with different degrees of renal…

Trial name

NCT07443059

Testing

Zovaglutide

Where

3 sites in China

Volunteers

40 people, healthy volunteers welcome

Sponsor

Beijing QL Biopharmaceutical Co.,Ltd